Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Clinical trial NCT07279194 · RECRUITING

Trial details

NCT number: NCT07279194
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity & Overweight

Start date: 2025-10-14
Primary completion: 2026-09-20
Enrollment: 825

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.